Alliancebernstein L.P. Point Biopharma Global Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$6.86 - $10.86 $484,659 - $767,259	70,650 Added 118.14%	130,450 $1.18 Million
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $688,753 - $822,846	-101,586 Reduced 62.95%	59,800 $434,000
Q4 2022 Feb 14, 2023	BUY	$5.72 - $9.78 $665,727 - $1.14 Million	116,386 Added 258.64%	161,386 $1.18 Million
Q3 2022 Nov 15, 2022	BUY	$7.24 - $10.31 $230,232 - $327,858	31,800 Added 240.91%	45,000 $348,000
Q2 2022 Aug 15, 2022	BUY	$5.6 - $9.5 $73,920 - $125,400	13,200 New	13,200 $90,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.